Skip to main content
. 2020 Jul 31;26(11):1557.e1–1557.e7. doi: 10.1016/j.cmi.2020.07.038

Table 2.

Percentage agreement between the different assays in COVID-19 patients (223 samples for sensitivity) (95% confidence interval)

Abbott Euro NCP Maglumi Mikrogen Diasorin Euro S1
Roche 94.6% (90.7–97.0) 95.1% (91.3–97.3) 89.7% (84.9–93.1) 91.5% (87.0–94.5) 84.3% (78.9–88.5) 90.1% (85.4–93.4)
Abbott 96.9% (93.5–98.6) 90.6% (86.0–93.8) 93.3% (89.1–96.0) 85.2% (79.9–89.3) 90.1% (85.4–93.4)
Euro NCP 87.4% (82.4–91.2) 95.5% (91.8–97.7) 84.8% (79.4–88.9) 88.8% (83.9–92.3)
Maglumi 96.4% (93.0–98.2) 85.7% (80.4–89.7) 87.9% (82.9–91.6)
Mikrogen 83.9% (78.4–88.1) 87.9% (82.9–91.6)
Diasorin 91.5% (87.0–94.5)